ComplianceOnline

Changes in Labeling Statin Drugs – What the New FDA Draft Guidance Says

  • By: Staff Editor
  • Date:April 16, 2012
Abstract:

On Feb 28 2012, the FDA released new draft guidance on safety changes for widely used cholesterol – lowering or statin drugs. These regulations aim to educate, update health care professionals and patients about the health benefits as well as risks associated with these drugs.

Bookmark and Share
Best Sellers
You Recently Viewed
    Loading